Kathrin Schoenborn

Kathrin Schoenborn is an accomplished leader in the healthcare and pharmaceutical sectors, currently serving as a Global Advisory Board member, Chair Emerita, and Global Board Director for the Healthcare Businesswomen’s Association since January 2021. As the founder of Kathrin Schönborn Consulting and an advisor for EndoGene.Bio, Kathrin brings extensive experience from a 27-year tenure at Merck Group, where roles included Vice President of Integrated Planning, Analytics & Partnering, and Senior Vice President of Global Clinical Operations. This background is complemented by project management expertise at Sandoz. Kathrin holds a Ph.D. in Natural Sciences from the University of Bonn and has completed various prestigious executive leadership programs.